Labetalol does not decrease placental perfusion in the hypertensive term-pregnant rat

This publication has 12 references indexed in Scilit:

• Dihydralazine and the uteroplacental blood flow
  American Journal of Obstetrics and Gynecology, 1988
• The effect of hydralazine on placental perfusion in the spontaneously hypertensive rat
  American Journal of Obstetrics and Gynecology, 1987
• Fetal Distress After Hydralazine Therapy for Severe Pregnancy-Induced Hypertension
  Southern Medical Journal, 1986
• The relationship between reproductive performance and blood pressure in the spontaneously hypertensive rat
  American Journal of Obstetrics and Gynecology, 1984
• Labetalol for the Treatment of Hypertension in Pregnancy: Pharmakokinetics and effects on the uteroplacental blood flow
  Acta Obstetricia et Gynecologica Scandinavica, 1984
• The Acute Effects of A Non-Selective β-Adrenergic Blocking Agent in Hypertensive Pregnant Rats
  Acta Obstetricia et Gynecologica Scandinavica, 1984
• Pharmacology of labetalol in experimental animals
  The American Journal of Medicine, 1983
• Labetalol: A Review of Its Pharmacology, Pharmacokinetics, Clinical Uses and Adverse Effects
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
• Acute Effect of Dihydralazine on Uteroplacental Blood Flow in Hypertension during Pregnancy
  Gynecologic and Obstetric Investigation, 1983
• Acute effect of an antihypertensive drug, labetalol, on uteroplacental blood flow
  BJOG: An International Journal of Obstetrics and Gynaecology, 1982